Product details & mandatory information
STIEPROXAL triple shampoo for stubborn dandruff in detail
STIEPROXAL is a product from the STIEPROX range, specially developed to combat stubborn, persistent dandruff and severe itching. It combines the proven anti-dandruff efficacy of ciclopiroxolamine with the anti-dandruff properties of salicylic acid. With the triple anti-dandruff care system, STIEPROXAL offers a targeted fight against the causes of dandruff. The salicylic acid dissolves the stubborn and adherent dandruff, while the panthenol nourishes and supports the regeneration of the scalp. The result is an easier-to-comb hair structure with more shine and suppleness. STIEPROXAL helps the scalp to regain its natural balance.
Dandruff is caused by an accelerated process of skin renewal, in which the skin cells renew themselves in a shortened cycle of 5-15 days instead of the normal 28 days. This causes the skin cells to clump together and detach from the scalp in larger, visible cell clusters, which causes the typical dandruff. One of the main triggers of this dandruff is a yeast fungus that is normally part of the healthy scalp flora but proliferates when dandruff occurs.
The STIEPROX series, which includes STIEPROXAL, contains the anti-dandruff active ingredient ciclopiroxolamine. This active ingredient inhibits the growth of the fungus and thus reduces the formation of new dandruff. At the same time, it relieves itching and normalises the scalp.
Discover the effective solution to stubborn dandruff and severe itching with STIEPROXAL from the STIEPROX range now.
Advantages
- STIEPROXAL is a triple shampoo
- Fights stubborn dandruff
- Reduces severe itching
Important notes
For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
The seller reserves the right to carry out a pharmaceutical check by our pharmacists on the quantity of the medicine ordered. This may result in reductions in your order for this product. The invoice amount will then be adjusted automatically.
The reason for this is our pharmaceutical duty of care.
